Guangzhou Tinci Materials Technology: The Invisible Chemist Powering the EV Revolution

I. Introduction & Episode Roadmap

In the summer of 2000, a 35-year-old chemist named 徐金富 Xu Jinfu registered a company in Guangzhou with RMB 5.1 million of capital and an 85% stake in his own name.¹ The business plan was unglamorous to the point of invisibility: make the thickeners, silicone oils, surfactants and conditioning polymers that go into shampoo, shower gel and hand soap. Nobody writes a business-school case about carbomer.

Twenty-six years later, that company sells more lithium-ion battery electrolyte than anyone else on earth. In the first half of 2026 alone, 广州天赐高新材料 Guangzhou Tinci Materials Technology shipped over 440,000 tonnes of the stuff — more than the entire global electrolyte industry produced in a year at the start of the last decade — and booked RMB 14.71 billion of revenue and RMB 2.86 billion of net profit, the latter up 968% year over year.²

That number is the whole story in miniature, and it is also a warning. A business whose profit can rise tenfold in twelve months can fall just as fast. It did, in fact, already: Tinci earned RMB 5.71 billion in 2022, then RMB 1.89 billion in 2023, then RMB 484 million in 2024 — a 92% collapse from peak to trough in twenty-four months.³⁴ Anyone who tells you Tinci is a compounder has not looked at the earnings series.

So what is this company, really?

The core paradox. Tinci sells a chemical commodity into a customer base of perhaps a dozen buyers who possess enormous bargaining power, in an industry where Chinese producers hold more than 80% of global output and capacity has repeatedly overshot demand.⁵ By every structural test, this should be a terrible business. And yet Tinci has led the world in electrolyte volume every year since 2015, and its share of the global market rose through the worst downturn the industry has ever seen — from roughly 28.8% in 2021 to 36.4% in 2023, on the numbers most commonly cited.⁶ The company did not win by having a better product. It won by having a lower cost of production, achieved through a specific and unusual piece of process engineering, and then by relentlessly buying, building and back-integrating everything upstream of that process.

A note on the numbers, up front. Tinci's market share is quoted inconsistently and investors should treat it with care. Research work circulated in late 2025 put the 2023 figure at 36.4%.⁶ The company's own Hong Kong listing materials were reported as citing 35.7%. Chinese trade press covering the 2025 annual report gave 32.2% on shipments of 720,000 tonnes, alongside the claim of a tenth consecutive year at number one.¹² These are not reconcilable without knowing whether the denominator is volume or value, global or China, and whether captive production counts. The direction of travel — up, and comfortably number one — is well established. The decimal point is not.

What this episode tests. Four claims sit at the centre of the bull case on Tinci, and each deserves to be examined against the company's own record rather than accepted:

That the 2015 acquisition of 东莞市凯欣电池材料 Dongguan Kaixin Battery Materials was a masterstroke of customer-access M&A. The purchase price and the earn-out outcome are both public, and the record is messier than the legend.
That liquid-phase 六氟磷酸锂 lithium hexafluorophosphate (LiPF6) synthesis is genuine, durable process power. Here the strongest evidence is not a press release but a criminal conviction.
That vertical integration produces a cost position that holds through the cycle. The 2024 profit-and-loss statement is the test, and it is not a clean pass.
That management allocates capital with discipline. A RMB 2.65 billion project that was approved at the top of the cycle and terminated five years later having built a wall and a road is the counterweight.⁸

Why now. Tinci enters the autumn of 2026 in the strangest position of its life: earning at a record run-rate, with capacity near full and LiPF6 prices roughly double year-ago levels, while simultaneously having lost its long-term supply contract with the customer that once accounted for more than half its revenue, terminated a flagship domestic project, watched three senior executives sell shares ahead of a planned Hong Kong listing, and staked hundreds of millions of dollars on factories in Texas and Morocco whose commercial logic depends on trade rules that have not been written yet.²⁹¹⁰¹¹

A word on the evidence. Tinci is a Shenzhen-listed company, which means its disclosure obligations are substantial and its filings are public through the CNINFO portal — annual and interim reports, board resolutions, fundraising-project progress tables, and, unusually useful for outside investors, formal minutes of investor relations meetings including the analyst question-and-answer session.²⁴ Since September 2025 it has also been filing listing materials with the Hong Kong Stock Exchange.[^26] Much of what follows draws on those documents rather than on commentary, because on this company the primary record is considerably more interesting — and in several places considerably less flattering — than the secondary coverage.

That is a genuinely interesting company. Let us start with shampoo.

↑ Back to Top

II. Fine Chemistry Roots: The Shampoo Era (2000–2007)

Xu Jinfu was, by 1995, a founder who had already built a successful business and experienced a subsequent failure.

Born in October 1964 in 富阳 Fuyang, Zhejiang, he studied chemistry at Hangzhou University and earned a master's degree from the 中国科学院 Chinese Academy of Sciences — an elite credential in 1980s China that shaped his technical trajectory.¹ His first commercial role was at 道明化学 Daoming Chemical, the predecessor to 蓝月亮 Blue Moon, China's dominant household-detergent brand. He earned his first substantial capital there, but at age 28, sold his entire stake to his classmate 罗秋平 Luo Qiuping and departed. He later described the exit as a straightforward contract entered and exited without drama or lingering claims.¹

Then came the setback. In 1993, he returned to Fuyang to partner with a local fertilizer plant on developing pharmaceutical raw materials. Within two years, the venture collapsed and consumed his capital entirely.¹ He returned to Guangzhou in 1995 on borrowed money and spent five years running a small trading and industrial outfit before incorporating Tinci on 6 June 2000.¹

That early failure shaped Tinci's balance-sheet philosophy. A founder who has experienced a total business loss often approaches capital structure with greater risk awareness. This background offers a plausible explanation for Tinci's pattern of funding expansion primarily through operating cash flow and targeted equity issuances rather than high leverage. However, claims that Tinci never diluted shareholders are inaccurate: the company raised capital repeatedly, including a 2014 private placement and a convertible bond issue that accrued interest into 2025.²¹³

Why shampoo chemistry was the right school. Personal-care ingredients appear low-tech, but manufacturing them requires precise chemical controls. A surfactant supplied for a commercial shampoo formulation must maintain strict batch-to-batch consistency, remain free of trace metals that discolour or destabilize products, and comply with rigorous customer quality audits. The core technical requirements are impurity management at parts-per-million thresholds, formulation science to control how minor additives alter whole chemical systems, and the ability to customize molecular structures to meet specific customer requirements.

These identical technical requirements apply to lithium-ion battery electrolyte manufacturing. An electrolyte is a solvent blend containing a dissolved lithium salt and specialized additives present at fractions of a percent. Trace water or metal contaminants in the mixture react with the salt to generate acid, corroding cell internals and degrading battery lifespan. While the target chemistries differ, the underlying quality and production standards match. Tinci transferred an established core manufacturing discipline into the battery market.

The personal-care business also provided essential cash flow while battery development remained in its early stages. Xu established a lithium-ion battery materials research team in 2005, but commercial-scale electrolyte sales were not realized until 2007 — two years of research funded by consumer product revenues.¹

The fine chemicals product suite Tinci developed during this period remains active in its operational filings. The lineup features surfactants, silicone oils, water-soluble polymers, cationic conditioning agents, organosilicon, and rubber additives. These inputs supply shampoos, conditioners, shower gels, hand washes, disinfectants, and skincare items, while extending into household cleaners, leather care, laundry products, and industrial applications across papermaking, construction, agrochemicals, oilfield services, rubber, and dyeing.² This broad portfolio demonstrates Tinci's strategy of developing core chemical capabilities that can be redeployed across multiple end markets. The expansion into battery materials followed this same structural approach.

Where that business sits today. Personal care and specialty chemicals generated RMB 686 million in revenue during the first half of 2026, representing 4.67% of Tinci's total sales, with a gross margin of 27.5%.² That segment gross margin decreased by 2.77 percentage points year over year even as group-wide gross margins expanded by nearly 15 percentage points — indicating that the legacy division functions as a mature specialty business rather than a primary profit driver. Segment revenue grew 11.78% year over year, maintaining steady performance relative to the battery division.²

The fine chemicals segment remains the division with Tinci's longest-standing international operations. The company established an early international presence in personal-care materials, spending over a decade building research, quality control, and environmental, health, and safety systems aligned with global standards.² This operational track record established the institutional infrastructure for international management before the overseas expansion of its battery business.

During Tinci's initial seven years, the personal-care division provided the company's sole operating cash flow, operating without outside venture capital, policy bank financing, or strategic equity partners. Funding battery chemistry research through fine chemical margins enabled internal capital allocation and allowed Xu Jinfu to maintain equity control 26 years later.

For financial analysis, the personal-care segment accounts for under 5% of current revenue and represents a mature contributor to earnings. Evaluating Tinci relies primarily on its performance in lithium battery chemistry. The central strategic issue is how an enterprise originating in specialty personal-care inputs established a low-cost production structure in battery supply chain manufacturing — an expansion that began in Jiangxi.

↑ Back to Top

III. The Strategic Pivot & The Liquid LiPF6 Revolution (2007–2014)

Around 2005, through contacts in the fuel-cell world, Xu Jinfu came to a conclusion that in hindsight looks obvious and at the time did not: lithium-ion batteries were going to be very large, and the chemicals inside them would be a real industry.¹ China at that point had essentially no domestic lithium salt production of consequence. The world's LiPF6 came from Japan and Korea — 森田化学 Morita Chemical, 関東電化 Kanto Denka, and Korean producers — and at moments of scarcity the salt had traded as high as RMB 1 million per tonne, an extraordinary rent extracted from a chemical that is, in the end, lithium fluoride plus phosphorus pentafluoride.⁶

What is actually inside a battery. A lithium-ion cell has four functional parts. The cathode is the positive electrode, the reservoir the lithium comes from — in China increasingly 磷酸铁锂 lithium iron phosphate (LFP). The anode is the negative electrode, usually graphite, where lithium parks when the cell is charged. The separator is a thin porous film that physically keeps the two electrodes from touching, which would cause a short circuit and a fire. And the electrolyte is the liquid that fills the space between them.

The useful analogy: if the cathode and anode are two riverbanks, the electrolyte is the river. Lithium ions have to swim from one bank to the other every time the battery charges or discharges, thousands of times over the pack's life. The river has to conduct ions but not electrons, survive being repeatedly frozen and cooked, remain chemically stable against two aggressive electrode surfaces, and not catch fire. It is roughly 10–15% of a cell's material cost and close to 100% of its failure modes.

The recipe has three parts. Solvents — ethylene carbonate, dimethyl carbonate, ethyl methyl carbonate — are the water of the river. The lithium salt, overwhelmingly LiPF6, is what dissolves in it to carry the charge; it represents something on the order of 43% to 52% of electrolyte cost depending on where in the cycle you measure, which is why whoever controls the salt controls the economics.⁶⁵ And additives — vinylene carbonate (VC), fluoroethylene carbonate (FEC), and a long tail of proprietary compounds — are present at under a percent each but do the hard work: they deliberately decompose on the anode surface during the first charge to build a protective film, the way a cast-iron pan is seasoned. Change the additive package and you change fast-charge capability, low-temperature performance and cycle life. This is where formulation know-how lives, and it is why electrolyte suppliers co-develop recipes with cell makers rather than selling from a catalogue.

The additive tail is longer and more interesting than the headline three. Beyond VC and FEC sit compounds such as DTD and lithium difluorophosphate, each tuned to a particular failure mode — gas generation at high temperature, capacity fade at high voltage, lithium plating during fast charge. A modern electrolyte formulation may carry half a dozen of these, and the exact combination is the part a cell maker will not let its supplier disclose. This is why the industry's language is "co-development" rather than "procurement," and it is the source of the switching friction that keeps qualified suppliers in place once they are in. It is also, importantly, a capability many suppliers possess. Formulation skill gets you into the room; it does not by itself win the contract.

The process breakthrough. Tinci established its Jiangxi manufacturing base, 九江天赐 Jiujiang Tinci, and began pushing on a question the incumbents had answered one way for fifty years: how do you make LiPF6?

The conventional route produces a solid, crystalline salt. You synthesise it, then crystallise it, then filter, dry, mill and package a substance that is violently reactive with moisture — LiPF6 exposed to humid air decomposes and releases phosphorus pentafluoride as a white fume.⁶ Every one of those steps costs capital, consumes energy, requires exotic moisture-excluded handling, and introduces batch-to-batch variation. Then the electrolyte maker has to unpack the crystals in a dry room and dissolve them again.

Tinci's approach was to ask why you would ever crystallise it at all, if the salt's final destination is a solvent anyway. The company industrialised a liquid-phase route: synthesise LiPF6 and keep it in solution, then pipe it directly into the electrolyte blending line. No crystallisation, no drying, no milling, no repackaging, no re-dissolving. The company states plainly in its filings that its liquid LiPF6 process delivers unit capital investment and production costs "significantly below the industry average" while cutting energy consumption and emissions.²

The capital-cost claim is testable against a hard historical number. When Tinci raised money via private placement in 2014, it allocated RMB 49 million to a 6,000 tonne-per-year liquid LiPF6 project.¹³ Roughly RMB 8,000 of capital expenditure per annual tonne of lithium salt capacity is a strikingly low figure for fluorine chemistry, and it is the single best piece of contemporaneous evidence that the process advantage was real rather than rhetorical — because it was disclosed in a fundraising document years before it became a marketing story.

Jiujiang, sitting on the Yangtze in Jiangxi, became and remains the company's largest production base and is described in industry research as the world's largest liquid LiPF6 manufacturing site.⁶ The river location was not incidental — bulk chemical logistics in China run on water, and Tinci's subsequent domestic build-out deliberately strung sites along the Yangtze corridor to radiate outward from it.⁶ By late 2025 the company operated fifteen domestic production bases through a structure of 41 wholly-owned and 14 controlled subsidiaries employing more than 6,700 people.⁶

There is a cost to this design, and it is worth naming: liquid LiPF6 does not travel well. A solid salt can be shipped anywhere; a solution is heavy, hazardous and economically transportable only over modest distances. That is why Tinci's plants cluster along the Yangtze and next to customers, and it is why the company's overseas expansion is far harder than simply exporting product. The process that makes Tinci cheap at home also makes it geographically captive.

The 2014 listing. Tinci went public on the Shenzhen Stock Exchange on 23 January 2014 under the code 002709, moving to the main board in February 2021.¹⁶ At the time of listing it was a mid-sized fine chemicals company with a promising side business. By the end of 2015 it had 137 patent applications on file and 51 granted.¹³ By the middle of 2026 those figures had reached 1,613 applications and 749 grants, plus 275 international applications filed through the Patent Cooperation Treaty with 31 granted.² That eleven-fold expansion in the patent estate is the clearest available proxy for how completely the company's centre of gravity shifted from formulation to process chemistry.

Being listed gave Tinci something more valuable than the cash: a currency. And within a year of the IPO, Xu Jinfu spent it on a small, unprofitable company in Dongguan that happened to have one thing he could not build.

↑ Back to Top

IV. The Catalyst M&A: Dongguan Kaixin & The CATL Alliance (2015–2020)

Qualifying as a battery cell maker's electrolyte supplier is not a sales process. It is an audit.

The customer will test your material in coin cells, then in single cells, then in modules, then in packs, running cycle-life and safety protocols that take months of real elapsed time because you cannot compress a thousand charge cycles into a weekend. They will inspect your plant, your quality system, your raw material traceability. They will qualify you on one cell model and require re-qualification for the next. Three to five years from first sample to meaningful volume is normal. And for a battery maker, switching electrolyte supplier mid-programme is genuinely risky, because the additive package is tuned to that specific cell design — which is exactly why incumbency in this business is worth so much.

Xu Jinfu decided not to wait. In 2015, funded by Tinci's first post-IPO private placement, the company bought 100% of Dongguan Kaixin Battery Materials for RMB 196.18 million.¹³ Kaixin's asset was not its plant, which added only about 5,000 tonnes of capacity to Tinci's existing 20,000.⁵ Its asset was that it was already inside the supply chain of ATL — the consumer-battery giant from which 宁德时代 CATL was spun out. Tinci's own 2015 annual report says so with unusual directness: the acquisition achieved "the objective of rapidly entering the supply chain of the internationally known lithium battery producer ATL," and made Tinci the global leader in electrolyte supply.¹³

That is the legend, and the strategic logic is sound: Tinci bought years of calendar time and a qualification credential that money alone could not accelerate. In the same year it also began supplying 比亚迪 BYD and Sony's Singapore operation.¹³

Now the part the legend leaves out. The deal came with a performance guarantee. Kaixin's net profit was to be no less than RMB 14 million in 2014, RMB 16.8 million in 2015 and RMB 20.16 million in 2016. Actual results were RMB 7.17 million in 2015 and a loss of RMB 6.06 million in 2016.⁵ Tinci's own 2015 annual report disclosed that the Kaixin project failed to achieve its forecast return, and explained why in terms that will sound extremely familiar eleven years later: LiPF6 input costs rose in the fourth quarter of 2015, but the price adjustments in contracts with major customers lagged, compressing gross margin — compounded by bad-debt provisions against receivables that had gone to litigation.¹³

So the honest verdict on the outline's framing — that Kaixin "generated tens of times its purchase price in cumulative economic value" — is that it is unverifiable and probably unknowable. What the record supports is narrower and still important: Tinci paid a modest sum for a customer relationship that it could not have built organically on the same timeline, and the acquired entity itself lost money almost immediately. The value was entirely in the option, not the asset. Investors should hold the claim at that reduced size. The deal was smart; it was not clean; and the same margin mechanism that broke Kaixin's earn-out is the mechanism that breaks Tinci's earnings in every downcycle since.

Co-location as strategy. What Tinci did with the relationship over the following five years is more impressive than the acquisition itself. Because liquid LiPF6 and finished electrolyte both travel badly, and because electrolyte degrades with time in transit, the company built plants next to its customers rather than shipping to them. By 2026 Tinci operated bases in Guangzhou, Jiujiang, Tianjin, Ningde, Yichun, Chizhou, Taizhou, Liyang, Fuding, Fogang, Yichang, Sichuan and Jiangmen.² Ningde, Liyang and Fuding are not coincidences — they are CATL's manufacturing heartland.

This is a real switching cost, and it is physical rather than contractual. A cell plant that has an electrolyte line across the fence, feeding a formulation co-developed for its specific cell, does not casually re-tender. But co-location cuts both ways, and Tinci learned how in 2025. A plant built to serve one customer at one site is a stranded asset if that customer diversifies. Which is precisely what happened.

The scale of the dependency was extraordinary. Sales to CATL represented 57.5% of Tinci's lithium battery materials revenue in 2021, and CATL alone accounted for 50.47% of total 2021 revenue.⁷⁵ Top-five customer concentration rose from 22.83% in 2013 to 66.89% in 2021 — while rival 深圳新宙邦 Capchem never let its top five exceed 40%.⁵ In 2023, CATL contributed roughly RMB 8.1 billion, more than half of group revenue.¹⁴ On 17 June 2024, CATL placed an order equivalent to 58,600 tonnes of LiPF6 running through the end of 2025 — estimated at around RMB 10 billion, covering an implied 410–470 GWh of cells, roughly 60% of CATL's expected output over the period. Tinci's stock hit its 10% daily limit before closing up 7.7%.¹⁴⁷

That was the high-water mark of the alliance, and it is important to date it precisely, because what happened when the contract expired is the subject of Section VII.

LiFSI: the next salt, and a lesson in patience. During this period Tinci also began commercialising 双氟磺酰亚胺锂 lithium bis(fluorosulfonyl)imide (LiFSI), a salt with better thermal stability and conductivity than LiPF6, particularly valuable for fast charging and long cycle life. The bull case has long been that LiFSI represents higher value per kilowatt-hour and a second moat.

The evidence for how slowly that converts is worth sitting with. At the August 2025 results briefing, management disclosed that LiFSI's addition ratio in Tinci's electrolyte products was approximately 2% in the first half of 2025, and expressed hope it could reach 2.2–2.5% as fast-charge and storage formulations grew.¹⁵ That is the real pace of chemistry adoption: a decade of development to move a component from zero to two percent of a blend. Separately, Tinci's dedicated 20,000-tonne LiFSI project — funded with raised capital — was disclosed in the 2026 interim report as having failed to meet its expected return, because raw material costs rose.² LiFSI is a genuine technology lead. It is not yet a profit engine, and the company's own disclosures say so.

By the end of 2020, Tinci had the customer, the process and the plants. What it did not have was any experience of what happens when everyone else notices.

↑ Back to Top

V. The Great Boom, Glut, and Vertical Integration Moat (2021–2026)

There is a specific kind of madness that grips a commodity chemical market when demand outruns capacity, and between 2021 and 2022 the LiPF6 market experienced the full clinical presentation.

Chinese electric vehicle demand went vertical. Power lithium battery shipments in China rose from 65 GWh in 2018 to 780 GWh in 2024, a compound rate of 51.3%.⁶ Every gigawatt-hour of cells needs electrolyte, every tonne of electrolyte needs lithium salt, and lithium salt capacity takes roughly two years to build and commission because fluorine chemistry requires environmental and safety approvals that cannot be rushed.⁶ The result was the textbook outcome: a step-change in demand meeting a fixed short-run supply curve.

LiPF6 prices, which had spent years in the RMB 70,000–100,000 per tonne range, peaked above RMB 590,000 per tonne in 2022.¹⁶ For a producer that was substantially self-supplied in the salt — Tinci had been building LiPF6 capacity since a 1,000 tonne-per-year line commissioned in the fourth quarter of 2015 — this was close to a licence to print money.¹³

The 2022 financial statements are worth reading slowly, because they define what the top of this cycle looks like. Revenue doubled to RMB 22.32 billion. Net profit attributable to shareholders rose 158.77% to RMB 5.71 billion. Operating cash flow was RMB 4.16 billion, comfortably exceeding profit. Earnings per share reached RMB 2.99. And weighted average return on equity hit 59.42%.¹⁶

Pause on that last figure. A 59% return on equity in a chemical manufacturing business is not a sign of a great franchise. It is a sign of a shortage. The outline's suggestion of "record ROE above 40%" understates what happened, and understating it makes the subsequent collapse harder to understand. When a business earns 59% on equity making a commodity, capital arrives. It always arrives.

The equity market responded exactly as equity markets do. Tinci's market capitalisation crossed RMB 100 billion for the first time in 2021, and the company moved from Shenzhen's small and medium enterprise board to the main board in February of that year.⁶ A fine chemicals company that had listed seven years earlier making shampoo ingredients was suddenly among the more valuable industrial businesses in China, on the strength of a salt.

It is worth pausing on what this period did to the internal narrative of the company. When a business earns nearly RMB 6 billion in a year having earned RMB 533 million two years earlier, the temptation to interpret that as evidence of a structural franchise rather than a temporary shortage is close to irresistible — and, as the incentive plan discussed later demonstrates, Tinci's board did not resist it.¹⁶

The crash. It arrived. Chinese LiPF6 effective capacity reached 392,900 tonnes by 2024 while actual output was only 183,800 tonnes — an industry running at roughly 47% utilisation in aggregate.⁶ Research work published by EV Tank found that most of the capacity planned in 2023 and 2024 was stalled, and that outside a handful of leaders, operating rates sat below 70%.⁶ Electrolyte prices fell from around RMB 85,000 per tonne in 2022 to roughly RMB 17,500 per tonne at the 2025 trough — a nearly 80% decline.¹²

Tinci's earnings did what earnings do in that situation. Net profit fell to RMB 1.89 billion in 2023 and then to RMB 483.9 million in 2024, with return on equity dropping to 3.66% and earnings per share to RMB 0.25.³⁴

Here is the analytically important part, and it is uncomfortable for the moat thesis. Tinci did not merely see reduced profits in 2024. It saw its return on equity fall to a level below what an investor could have earned on a Chinese government bond, in a year when it was already the global cost leader with the deepest integration in the industry. Vertical integration did not prevent that. It cannot prevent it. When the marginal producer prices at cash cost, the low-cost producer's margin compresses toward the difference between their cash costs, not toward some protected level. Integration determines who survives; it does not determine whether anyone earns an adequate return.

The strongest version of the moat claim that survives 2024 is this: Tinci's integration buys survival and share gain through the trough, and it converts a cyclical recovery into an exceptionally violent earnings recovery on the way out. Both halves of that were then demonstrated in real time.

The recovery, and what it reveals. Through 2025 the industry began to clear. Utilisation of Chinese LiPF6 capacity reached 78.8% by September 2025, up 14.4 percentage points year over year.⁶ Meanwhile demand found a second engine that almost nobody had modelled: grid and data-centre energy storage. Chinese energy-storage lithium battery shipments went from 9.5 GWh in 2019 to 335 GWh in 2024, and reached 430 GWh in just the first three quarters of 2025, up 99%.⁶

At the August 2025 results briefing — a moment when Tinci had just reported half-year net profit of RMB 268 million, a barely-there 12.79% increase — Xu Jinfu and CFO 顾斌 Gu Bin told analysts from UBS, Goldman Sachs and Citigroup that the industry had been running at the bottom for a sustained period, that capital expenditure across the chain was falling, and that prices should "gradually return to healthy recovery."¹⁵ Asked specifically about LiPF6 supply and demand, management said the top three suppliers were already running at relatively high utilisation while cost-disadvantaged capacity sat idle or ran at low load, and that Tinci had debottlenecking headroom it was deliberately choosing not to deploy.¹⁵

That answer aged extremely well, and it is a genuine mark in management's favour on the credibility ledger: they described the mechanism of the recovery a quarter before it showed up in the numbers, and they said they would withhold supply rather than chase volume.

The fourth quarter of 2025 delivered RMB 941 million of net profit — roughly 70% of the full year's earnings in three months.³¹⁷ Full-year 2025 revenue reached RMB 16.65 billion, up 33%, with net profit of RMB 1.36 billion, up 181.43%.³ By the first half of 2026 the average LiPF6 price had reached RMB 118,558 per tonne, more than double the prior-year half, and LFP-grade electrolyte averaged RMB 30,877 per tonne, up 35%.¹⁸ Tinci's electrolyte gross margin expanded 16.67 percentage points, plants ran near full, and energy-storage electrolyte volumes more than doubled.²

The cost-position evidence — and a disclosure gap. How much of that outperformance is genuine cost advantage rather than a rising tide? The peer comparison for the first half of 2026 is informative. Tinci's net profit rose 968%; Capchem's rose roughly 103% on revenue of RMB 7.46 billion; 多氟多 Do-Fluoride guided to a 777–991% increase.¹⁹ Do-Fluoride, a salt specialist, saw operating leverage similar to Tinci's. Capchem, which blends electrolyte but buys much of its salt externally, captured far less. That is consistent with the integration thesis: the money in this cycle is in the salt, and whoever owns the salt captures it.

Investors should note, however, that Tinci does not publish a clean, consistent self-sufficiency ratio. The outline's figures of 99.0% for LiPF6 and 96.6% for LiFSI are not traceable to the company's disclosed filings. Public statements have ranged from approximately 80% in mid-2025 to figures in the high 80s and above 97% depending on the source and the date. The 2026 interim report says only that the self-supply proportion "rose steadily," without a number.² For a metric the entire bull case rests on, that is a meaningful disclosure gap, and it is the single most useful thing management could fix.

The adjacent bets. Tinci also pushed into 磷酸铁 iron phosphate and LFP cathode material, a market that suffered even worse overcapacity than electrolyte. The 2026 interim report discloses that this business only achieved monthly breakeven during the period, as low-end capacity exited and prices reset.² Management has developed fourth- and fifth-generation LFP products and claims an energy-consumption advantage in production.¹⁵² It is a reasonable adjacency — same customers, same plants, shared precursor chemistry — but it has consumed capital for years while contributing losses, and "monthly breakeven" in a boom year is a low bar.

The recycling business is the more interesting of the two adjacencies, because it feeds the core. Tinci processes spent batteries into lithium carbonate that goes back into its own salt production, giving it a lower-cost, lower-carbon input and — critically — recycled-content credentials that the European Union's battery regulation will require.²¹⁵ Management has been explicit that lithium mining investment will be approached cautiously while recycling is expanded, and the company has been conducting exploration and offtake work in Nigeria and Zimbabwe rather than buying mines outright.¹⁵² That is a defensible posture from a company that has watched peers destroy capital on upstream resources.

Which brings us to the harder question: is this management team actually disciplined, or has it simply been lucky twice?

↑ Back to Top

VI. Current Management, Ownership, & Governance Stress Test

On 3 July 2026, Tinci announced that its subsidiary in Nantong was terminating a project to build 243,000 tonnes of annual lithium and fluorine-containing new materials capacity, with a planned total investment of RMB 2.654 billion.⁸

The project had been approved by an extraordinary general meeting in September 2021 — the absolute peak of the cycle — originally as a 350,000-tonne first phase at RMB 1.766 billion, then enlarged in 2022 by merging the two phases and raising the budget by half.⁸ It was filed with the authorities in August 2022 and obtained environmental and energy assessment approvals. By 2024, construction consisted of levelled land, a perimeter wall and a road. As of 30 June 2026, cumulative construction-in-progress stood at RMB 9.36 million.⁸

The stated reasons were candid: capacity across the industry had expanded from the second half of 2023 while demand disappointed; the company's existing 200,000-tonne Liyang plant sat closer to major customers with lower logistics costs; and fluorine materials process technology was iterating so quickly that the originally specified products would not have been competitive.⁸ The market's response was a 9.33% single-day decline, taking the stock roughly 25% below its May 2026 high of RMB 64.98.¹⁰

How should an investor score this? There are two readings and both are partially right.

The generous reading: management stopped. It spent RMB 9.36 million and walked away rather than spending RMB 2.65 billion into a glut. Compared with the Chinese industrial norm of building anyway because the land has been allocated and the local government is watching, that is genuinely creditable capital discipline, and it was executed in the same quarter the company was reporting record profits — the easiest moment to justify carrying on.

The sceptical reading, which deserves equal weight: the project was approved at a cyclical peak on a demand forecast that proved wrong, sat frozen for two full years while the annual reports continued to carry it, and was only formally killed five years after approval. Approving RMB 2.65 billion of capacity at the top and cancelling it at the next top is not evidence of foresight. It is evidence of a company that got caught by the cycle, and then had the sense not to compound the error.

And Nantong is not isolated. The 2026 interim report's fundraising-project disclosures are a quietly damning read. The 20,000-tonne LiFSI project missed its return target on input costs. The 62,000-tonne electrolyte base materials project and the first phase of the 60,000-tonne personal care base materials project both missed on weak demand and low operating rates. The first phase of a 41,000-tonne lithium battery materials project was slowed, and in July 2026 the board and shareholders approved restructuring it: the front-end synthesis section moved to self-funding, with remaining proceeds redirected into a 250,000-tonne electrolyte expansion.² Separately, the company has repeatedly moved leftover raised capital into general working capital — RMB 507.8 million by January 2024, RMB 83.9 million in December 2024, and approximately RMB 300 million of unpaid contract retentions transferred on the same basis.² It also borrowed RMB 700 million of idle raised funds for working capital in December 2024, returning it in December 2025.²

None of these individually is scandalous; all are disclosed and shareholder-approved. Collectively they describe a company that has raised money for specific projects and then repeatedly repurposed it. Any activist looking at Tinci would start here, and would ask a fair question: if the integration strategy is as high-return as management says, why has so much of the capital raised to execute it ended up funding the working capital of a business with rapidly growing receivables?

The target-setting record. The sharpest available test of management's forecasting discipline is the 2022 restricted stock incentive plan, announced in August 2022. Tinci granted 5.51 million shares to 572 employees at RMB 6 per share, with company-level performance conditions of net profit no less than RMB 3.8 billion in 2022, RMB 4.8 billion in 2023, and RMB 5.8 billion in 2024.²⁰

Actual results: RMB 5.71 billion, RMB 1.89 billion, RMB 483.9 million.¹⁶⁴ The 2022 target was cleared by half. The 2023 target was missed by 61%. The 2024 target was missed by 92%.

This is the single most important thing to understand about how this management team forecasts. In mid-2022, at the top of the most extreme shortage in the industry's history, Tinci's board set three-year escalating profit targets that implicitly assumed peak conditions would persist and improve. That was not a small misjudgement of timing; it was a structural misreading of the company's own cyclicality by the people who know it best. Anyone tempted to extrapolate the 2026 earnings run-rate should sit with that fact for a moment.

The successor plan is more modest in its visible outcomes: under the 2024 stock option plan, approved at the end of December 2024 with an exercise price twice adjusted to RMB 16.59, the first exercise window covered 4,670,157 options across 800 grantees, while 1,447,443 options were cancelled owing to departures, waivers and failed performance appraisals.²¹ The cancellation rate is worth noting — roughly a quarter of the tranche — which at least suggests the appraisal conditions bind.

Ownership. Xu Jinfu held 34.35% of the company at the end of 2025 — 698.67 million shares, of which 524 million were subject to lock-up restrictions.³ That is meaningful founder control, though below the "36%+" the outline suggests, and it is direct rather than held through pyramids or opaque vehicles. Two other individual holders in the top ten are family: 徐金林 Xu Jinlin, the chairman's younger brother, at 1.07% with 5.2 million shares pledged, and 林飞 Lin Fei, the husband of the chairman's wife's sister, at 1.52%.³ The annual report states there is no concert-party agreement among them.³ Related-party proximity of this kind is common in Chinese listed manufacturers and is not by itself a red flag, but it is a governance fact investors should hold.

The share sales. Between 11 February and 27 March 2026 — after the blockbuster 2025 results and during the preparation of the Hong Kong listing — three senior executives sold shares: Vice Chairman 徐三善 Xu Sanshan, director and CFO Gu Bin, and Vice General Manager 石立涛 Shi Litao. The combined disposal was 673,000 shares at prices between RMB 41 and RMB 51, about RMB 31.58 million and 0.0331% of shares outstanding.¹¹ The executives cited personal financial needs and said they remained confident in the company's prospects.¹¹

In absolute terms this is a small sale. In signalling terms it is not nothing: senior management, including the finance chief, reducing exposure into strength immediately before marketing an international offering is the kind of thing a short-seller puts on a slide. The scale argues against reading too much into it. The timing argues against dismissing it entirely.

The accounting judgments worth knowing about. Two acquisitions sit on the balance sheet in instructive states. In December 2022 Tinci took 56.72% of 郴州中贵 Chenzhou Zhonggui through a RMB 76.08 million capital injection, recognising RMB 14.32 million of goodwill — which the company has since written off in full.² That is a small sum, but it is a concrete data point against any characterisation of Tinci as a company that does not make bad acquisitions: it made one, and it wrote it to zero.

The larger and still-live item is 东莞腾威 Dongguan Tengwei, 85% of which Tinci acquired for RMB 382.5 million with an effective date of 28 February 2023, generating RMB 200.4 million of goodwill that remains on the books.² The company tests it using a five-year discounted cash flow with a zero terminal growth rate and, in the most recent period, a 12.48% discount rate; the key inputs — expected selling price, sales volume and gross margin — are set by management from historical experience and market forecasts. No impairment was recognised in the period.²

That disclosure is appropriately detailed, and the zero terminal growth assumption is conservative. But investors should recognise what it means: a RMB 200 million asset whose carrying value rests on management's own forecasts of price and margin in a business whose price and margin have swung by a factor of five in four years. In a boom half-year, the test passes easily. The time to watch it is the next trough, and the fully-impaired Chenzhou goodwill shows the company does eventually take the charge when the forecast breaks.

Structural complexity as an activist target. A group operating fifty-five consolidated subsidiaries across fifteen domestic sites, two overseas construction projects, a Singapore holding company, a Korean laboratory, mineral exploration in two African countries, a battery recycling operation, an LFP cathode business and a personal-care chemicals division is not a simple company to audit or to value.⁶² Tinci also runs a systematic lithium carbonate futures hedging programme, which it discloses as a deliberate policy to damp input volatility.² Each piece has a rationale. Collectively they create the conditions under which a skeptical investor would ask whether the LFP cathode business — a segment that only reached monthly breakeven in a boom half-year — earns its place, and whether the group's reported consolidated margin is telling investors what they think it is telling them.

Narrative consistency. Across the August 2025 briefing and the 2026 interim report, management's story has been notably stable: integration, cost, cautious capacity deployment, patience on lithium resources, and steady progress on solid-state materials.¹⁵² The company answers analyst questions on pricing and credit impairment in specific, mechanical terms — the mid-2025 credit impairment, management explained, was a policy-driven provision against receivables ageing with no single-item write-downs.¹⁵ That is a concrete answer, not an evasion.

What management has not done is set a public multi-year financial target since the 2022 plan detonated. Whether that reflects learned humility or reduced accountability is a matter of judgement. The board did adopt a market value management system in December 2024 but has not published a valuation enhancement plan.²

The place where all these threads — capital discipline, customer power, geopolitics — are being tested simultaneously is 12,000 kilometres from Jiangxi.

↑ Back to Top

VII. Global Footprint & Geopolitical Risk Radar

In November 2025, ground was broken in Texas on Tinci's first North American electrolyte plant: roughly USD 200 million of investment for 200,000 tonnes of annual capacity.⁹ Three months later, in February 2026, construction began at Jorf Lasfar in Morocco on an integrated electrolyte and raw materials base — MAD 2.576 billion, about USD 280 million, for 150,000 tonnes of annual capacity.⁹ The corporate plumbing runs through Singapore: Singapore Tinci holds 100% of Morocco Tinci, which in turn holds the Jorf Lasfar entity.²

The Morocco choice is the more strategically elegant of the two. Morocco has a free trade agreement with the United States, association agreements with the European Union, and — crucially for this specific chemistry — domestic phosphate resources, which is the "P" in LiPF6, and an established fluorine and phosphate processing industry around Jorf Lasfar. A plant there can plausibly serve European gigafactories with short logistics and can plausibly present a non-Chinese origin. That is the bet.

The bet's dependency. Whether it pays depends entirely on rules that are still being contested. United States Inflation Reduction Act provisions restricting benefits where a "foreign entity of concern" is involved reach beyond nationality of incorporation into questions of ownership, control, and licensing relationships. A Chinese-controlled subsidiary in Morocco or Texas is exactly the structure those rules were drafted to scrutinise. The European Union's battery regulation adds carbon-footprint and recycled-content requirements that cut both ways — Tinci's recycling integration helps there, its coal-heavy Chinese power mix does not.

Tinci's own risk disclosure is unusually direct on this point. The 2026 interim report warns that overseas projects must comply with local environmental requirements and carry execution uncertainty, that persistent inflation in the United States and Europe has made the international environment more complex, and that uncertainty in relations between countries may affect both the Chinese battery supply chain and the company's overseas capacity construction.² Management is not selling certainty here, which is to its credit.

The size of what is actually at risk. Here is the number that should anchor any discussion of Tinci's globalisation: overseas revenue in the first half of 2026 was RMB 444 million, or 3.02% of the total.² It grew 42% year over year, and overseas electrolyte sales specifically grew more than 126% on the back of European and North American toll-manufacturing arrangements coming online.² But it is growing from almost nothing.

This matters in two directions. The bear reading is that Tinci is, for practical purposes, a Chinese domestic business with an international project pipeline, and that if the FEOC rules bite hard, it will remain one. The bull reading is that the downside is already in the numbers — 3% of revenue cannot fall much further — while the upside from a 350,000-tonne combined overseas capacity base serving markets where Chinese competition is excluded would carry structurally higher margins. The company explicitly frames raising the share of higher-margin overseas exports as a hedge against domestic price volatility.²

There is also a subtler question about what "overseas capacity" even means for this company. Because liquid LiPF6 is not economically shippable, a genuine overseas plant has to replicate the whole integrated stack — salt synthesis, additives, blending — not merely install mixing tanks. Morocco is being built that way, as an integrated base for electrolyte and core raw materials.⁹ Texas, at USD 200 million for 200,000 tonnes, is capitalised at a level that suggests something closer to blending than full integration; the company has not disclosed the precise scope split. If the North American plant ends up importing Chinese salt to blend locally, it inherits both tariff exposure and origin-rule scrutiny, and it does not carry Tinci's core cost advantage with it. That distinction is the single most important thing to watch as these projects commission, and it is not currently spelled out in the disclosures.

The honest assessment is that this is an option, not an earnings stream, and it should be valued as one. The event that would confirm it is overseas revenue crossing into double-digit percentages of the total with margins visibly above the group average. The event that would falsify it is a FEOC determination or tariff structure that renders the Texas plant's output ineligible for the incentives its customers need.

Customer concentration: the live wire. The June 2024 CATL agreement expired on 31 December 2025. As of the most recent public disclosures, no replacement long-term agreement had been announced; the company said it would disclose one if signed.⁷ Meanwhile, CATL's electrolyte volume began flowing elsewhere: Capchem signed for an estimated 300,000 tonnes across 2026–2028 and 永太科技 Yongtai Technology announced expected procurement of roughly 470,000 tonnes over the same period.¹⁰

Tinci's response was to go and find other customers, at speed. Between July and November 2025 it signed long-term agreements with 楚能新能源 CORNEX, 瑞浦兰钧 REPT BATTERO, 中航锂电 CALB and 国轩高科 Gotion High-tech totalling roughly 2.945 million tonnes — around five times its 2024 shipment volume — with roughly 80% of planned 2026 capacity pre-allocated.⁷ Over the following year the cumulative long-term commitment book passed 3.4 million tonnes.

Management has publicly denied a rupture, stating that the two companies remain highly interdependent and that both the Liyang and Fuding bases can supply CATL.¹⁰ The revenue data supports gradual dilution rather than a break: CATL's share of Tinci's lithium battery materials revenue fell from 57.5% in 2021 to 45.6% in 2024, and its share of total revenue from 50.47% in 2021 to 39.96% in 2024 to about 36.1% in 2025, with the top five accounting for roughly 60%.⁵⁷¹⁰

It is worth being precise about why this is not simply a story of a supplier being punished. CATL is the largest battery manufacturer in the world and publishes its own investor materials describing a global manufacturing footprint spanning China and Europe.²⁵ A buyer of that size, running a supply chain that must never stop, has a fiduciary obligation to itself to hold multiple qualified sources for every critical input. Concentrating 60% of eighteen months of electrolyte demand with one supplier was always the anomaly, and its unwinding was always more likely than its continuation. The strategic error, if there was one, belonged to Tinci for allowing half its revenue to rest on a relationship it could not control — not to CATL for behaving rationally.

What this actually tells us about the moat. The co-location and formulation switching costs described earlier are real but bounded. CATL demonstrated that it can and will multi-source at scale, and it did so at the moment the cycle turned in the supplier's favour — which is exactly what a powerful buyer does. The correct conclusion is not that Tinci's moat is fake; it is that the moat protects Tinci's cost position rather than its pricing power with any individual customer. Tinci can be the lowest-cost producer and still be a price-taker to CATL. Those two things are entirely compatible, and 2024's 3.66% return on equity is what they look like when they collide.

Solid-state. The long-horizon technology risk is that all-solid-state batteries eliminate liquid electrolyte. Tinci is working on both sulfide and oxide solid electrolyte routes; the sulfide route was at pilot stage as of August 2025, supporting materials validation with downstream battery customers, with a pilot production line targeted for completion during 2026.¹⁵ By mid-2026 the company reported a systematic patent portfolio spanning material, structure and interface stability for solid electrolytes.²

Apply the standard discipline: a patent estate and a pilot line are not revenue. Tinci's own history with LiFSI — a decade to reach a 2% blend ratio — is the relevant base rate for how fast this company converts materials science into meaningful sales. The nearer-term reality is that semi-solid and polymer/gel intermediate designs still require liquid or gel electrolyte and additive packages, which is why Tinci's own risk disclosure frames solid-state as affecting "a certain segment" of the market rather than eliminating the business.² The threat is real on a ten-year view and modest on a three-year view. Investors sizing it should watch for a named customer taking qualified volume, not for another announcement.

↑ Back to Top

VIII. Strategic Frameworks: Helmer's 7 Powers & Porter's 5 Forces

Strip away the narrative and ask the war-game question: if a well-funded rival wanted to take Tinci's position, what exactly would stop them?

Scale Economies — strong, and demonstrably so. Tinci shipped more than 720,000 tonnes of electrolyte in 2025 and over 440,000 tonnes in the first half of 2026 alone.⁷² Research and development spending reached RMB 614 million in that half-year, up 39.88%.² Spread across 440,000 tonnes, that is roughly RMB 1,400 per tonne of R&D burden; a competitor at a tenth the volume carries ten times that per-tonne cost to match the effort. The scale advantage in this industry is also physical: an integrated site that makes its own hydrofluoric acid, phosphorus compounds, lithium salt, additives and finished blend captures heat, by-products and logistics savings at each interface that a standalone blender cannot replicate. This is the most secure of Tinci's powers.

Process Power — strong, and unusually well evidenced. Most claims of proprietary process advantage are unfalsifiable marketing. Tinci's is not, and the proof came from an unexpected direction. On 15 September 2025 the Jiujiang Intermediate People's Court issued a final criminal judgment concerning theft of Jiujiang Tinci's liquid LiPF6 production process technology. 李胜 Li Sheng, who had worked at Jiujiang Tinci from August 2017 to May 2021 in roles including factory director and chief engineer, was sentenced to three years and three months' imprisonment with a RMB 4.5 million fine and RMB 2.835 million of illegal gains confiscated; 郑飞龙 Zheng Feilong received two years and three months with a RMB 1.5 million fine.[^22] The corporate recipient, 浙江研一 Zhejiang Yanyi, was fined RMB 20 million as a corporate defendant, having reportedly paid close to RMB 3.2 million for the information.[^22]

Read that as competitive intelligence rather than legal news. A rival attempted to acquire this process by paying insiders millions of renminbi and accepting criminal exposure, which is powerful evidence that it could not be reverse-engineered from the outside or licensed. Few moats get validated this precisely.

The associated civil action is a live overhang in both directions. Jiujiang Tinci has claimed RMB 887 million plus RMB 1.15 million in legal costs from twelve parties including Yongtai Technology and Yongtai Gaoxin; as of the last disclosed status the case had not been heard.[^22] Yongtai counter-sued in July 2025 for defamation, seeking RMB 57.5 million plus nominal damages, alleging Tinci's public announcements wrongly associated it with the theft.[^22] Tinci did record compensation received in a trade-secret infringement matter as a non-recurring gain in the first half of 2026, though the sum was not separately quantified in the interim report.² Investors should treat the RMB 887 million claim as unrealised and contingent, not as an asset.

Cornered Resource — moderate, and often overstated. The permits are genuinely hard to obtain. Building fluorine chemistry capacity in a Chinese chemical industrial park requires 环评 environmental impact assessment and 安评 safety assessment approvals, hazardous materials storage authorisation, energy assessment and fire acceptance, and Tinci's own filings list project approval delay as a standing risk.² But note what the Nantong story proves: Tinci held all of those approvals for that site and the project still failed on economics.⁸ Permits raise the entry cost; they do not create scarcity when incumbents have already overbuilt. Call this a barrier, not a cornered resource.

Switching Costs — real but bounded, for reasons already established by CATL's behaviour. Branding — negligible; nobody buys electrolyte on brand. Network Economies — absent. Counter-Positioning — absent; Tinci's advantage is a better version of what everyone does, not a business model incumbents cannot copy for fear of cannibalisation.

Now the five forces.

Buyer power: high, and the defining feature of the industry. The customer list is short and each name is enormous. CATL, BYD, 亿纬锂能 EVE Energy, CALB, Gotion and REPT Battero collectively represent the overwhelming majority of addressable demand. These buyers qualify multiple suppliers as policy, possess complete visibility into their suppliers' input costs, and structure contracts as cost-plus formulas linked to lithium carbonate and LiPF6 benchmarks. The mechanism that this creates is precisely what Tinci's 2015 annual report described when Kaixin's earn-out failed and what the risk factors describe today: when input prices move up, the pass-through lags, and the supplier absorbs the gap.¹³²

Supplier power: low, by construction. This is where Tinci has spent fifteen years and most of its capital. It makes its own lithium salt, additives, iron phosphate precursor and increasingly its own lithium carbonate via mineral processing and battery recycling.² It hedges lithium carbonate with exchange-traded futures to damp input volatility, a practice it discloses explicitly.² The residual exposure is to fluorspar, hydrofluoric acid feedstock and lithium itself, which is why the Nigeria and Zimbabwe exploration work exists.

Threat of new entrants: low today, for the wrong reason. It is not that entry is technically impossible; it is that entry is economically insane. With aggregate Chinese LiPF6 utilisation below 50% as recently as 2024 and only 239,000 tonnes of new capacity scheduled across 2025–2027 industry-wide, a new entrant would be adding supply into a market that has spent three years digesting a glut.⁶ Barriers are cyclical here, and they will weaken at the top of the cycle — which is now.

Threat of substitutes: low near-term, material long-term. Semi-solid and polymer designs still consume liquid or gel electrolyte and lithium salts; sodium-ion, which Tinci is also supplying with NaPF6 and NaFSI-based formulations, substitutes the chemistry but not the business model.² All-solid-state at scale is the genuine threat, and it is a decade-scale question.

Rivalry: high and structurally so. Capchem is the closest analogue and a genuinely well-run counter-example — it never allowed top-five concentration above 40%, it internationalised earlier, and in the first half of 2022 its overseas revenue was 15.14% of sales against Tinci's 3.05%.⁵ The strategic trade is now visible in both companies' results: Tinci took concentration risk and integration risk and earned a 968% profit increase in the up-cycle; Capchem took diversification and earned roughly 103%, with far less drawdown in 2024.²¹⁹ Do-Fluoride competes head-on in salt with roughly 13% of Chinese LiPF6 capacity against Tinci's 24%.⁶ 瑞泰新材 Ruitai and its Guotai Huarong business remains a credible third force in blending.

Neither strategy is obviously superior. Tinci's is higher-beta, and investors should own it knowing that.

The war-game verdict. Suppose a rival with unlimited capital set out to displace Tinci tomorrow. It would need to build integrated fluorine and phosphorus chemistry with environmental and safety approvals that take years and are increasingly rationed; it would need to independently invent or license a liquid-phase salt process that the courts have now established is a protected trade secret worth stealing; it would need to place plants adjacent to customer gigafactories that already have an incumbent across the fence; and it would need to endure a qualification cycle measured in years while carrying the fixed costs of all of the above. That is a formidable stack, and it explains why the industry has consolidated toward three or four credible integrated players rather than fragmenting.

But the same war-game exposes the limit. None of those barriers prevents an existing qualified competitor — Capchem, Do-Fluoride, Yongtai, Ruitai — from taking incremental volume when a large buyer decides to rebalance, because the qualification cost has already been paid and the marginal decision is about price. Tinci's moat is excellent against entrants and merely adequate against incumbents. In an industry where the incumbents are themselves large, listed, well-capitalised and, in Capchem's case, now also pursuing a Hong Kong listing to fund international expansion, "adequate against incumbents" is where the margin actually gets set.

↑ Back to Top

IX. Investment Spine & Bear vs. Bull Case

Every cyclical company presents investors with the same trap: the numbers look best exactly when the risk is highest. Tinci in September 2026 is a textbook specimen. So it is worth setting out plainly what has to be true for this to work from here, and what would break it.

Myth versus reality

Myth: Tinci's vertical integration means it makes money through the cycle. Reality: it made a 3.66% return on equity in 2024 and its earnings fell 92% from the 2022 peak.⁴¹⁶ Integration determines relative position, not absolute returns. What the record does support is that Tinci survived a trough that idled most of the industry, and gained share doing it.

Myth: the Dongguan Kaixin deal was a masterstroke that returned many multiples of its cost. Reality: the acquired company missed all of its earn-out targets and the parent disclosed in its own annual report that the project failed to meet forecast returns.⁵¹³ The strategic option was valuable; the asset was not.

Myth: management is a disciplined capital allocator. Reality: mixed, and improving. Nantong was killed cheaply, which counts.⁸ But it was approved at a cycle peak, and several other funded projects have underdelivered while leftover proceeds have repeatedly migrated into working capital.²

Myth: LiPF6 prices collapsed to RMB 50,000–60,000 per tonne and remain there. Reality: that was the 2024–25 trough. By the first half of 2026 the average had roughly doubled to RMB 118,558 per tonne.¹⁸ Anyone underwriting Tinci on trough prices today is underwriting a market that no longer exists — and anyone underwriting it on current prices is doing something more dangerous still.

Myth: Tinci is becoming a global company. Reality: 96.98% of first-half 2026 revenue came from inside China.²

The bull case, and the evidence behind it

Cost leadership with demonstrated operating leverage. The strongest single piece of evidence is not a self-reported ratio but the first-half 2026 peer spread: Tinci's near-tenfold profit increase against Capchem's doubling on comparable end-market conditions.²¹⁹ That gap is what owning the salt looks like when the salt reprices. It is corroborated by the disclosed capital cost of Tinci's liquid LiPF6 line and by a rival's willingness to commit crimes to obtain the process.¹³[^22]

Consolidation through the trough. Share rose while the industry lost money, and the customer book was rebuilt at scale after the CATL contract lapsed — roughly 2.95 million tonnes of long-term commitments signed inside five months, with about 80% of 2026 capacity pre-sold.⁷ Whatever one thinks about losing the anchor customer's exclusivity, the commercial team replaced the volume quickly and diversified the revenue base in the process. That is a better outcome than the alternative.

Energy storage as a second demand engine. The doubling of Chinese energy-storage battery shipments in the first nine months of 2025 and the more-than-doubling of Tinci's storage electrolyte volumes in the first half of 2026 point to a demand driver that is not the electric vehicle cycle and is being pulled by grid buildout and data-centre power.⁶² This genuinely changes the shape of the addressable market.

Optionality in LiFSI, sodium-ion and solid-state. Real, and worth something. But priced honestly, it is worth a fraction of what the narrative implies, for the reason established earlier: this company's demonstrated conversion rate from materials breakthrough to revenue is slow.

The bear case, and where it bites

The commodity trap is not a metaphor. The mechanism has now recurred three times in the company's disclosed history — 2015, 2023–24, and in the pass-through lag management itself flags as a standing risk.¹³² Contracts are formula-priced; when inputs rise, the customer's price adjusts on a lag; when inputs fall, the customer expects the saving. Tinci's own risk disclosure states that sustained sharp fluctuation in main raw material prices will cause production cost volatility and affect profit.² With lithium carbonate futures having roughly doubled within a year, that risk is currently pointing at the cost line, not away from it.¹¹

The receivables problem, which deserves far more attention than it gets. In the first half of 2026 Tinci earned RMB 2.86 billion of net profit and generated RMB 397 million of operating cash flow — down 2.91% year over year, in a period when profit rose almost tenfold.² Accounts receivable reached RMB 10.74 billion, or 33.48% of total assets, up from RMB 6.88 billion and 25.55% at the end of 2025.² The company booked RMB 152 million of credit impairment in the half.² Receivable turnover had already lengthened from roughly 65 days in 2022 to around 130 days by 2024–25.¹²

This is the most important unresolved question in the accounts. Some of it is mechanical — revenue more than doubled, so receivables should rise. But receivables rose faster than revenue, cash conversion fell to roughly 14% of net income, and Tinci is extending increasing credit to battery manufacturers, several of which are themselves loss-making in a fiercely competitive market. Management's own risk disclosure acknowledges the mechanism precisely: financial strain in the electric vehicle chain transmits through the cell makers to the materials suppliers, and the company says it manages credit terms dynamically and will if necessary control shipments or seek litigation preservation to protect collection.² That is an unusually frank statement of a real hazard. An investor who ignores it because the profit line looks spectacular is making the same mistake the 2022 incentive plan made.

Buyer power that has already been exercised. Discussed above; the point for the bear case is that it happened at the moment of maximum supplier leverage, which tells you what it will look like at the moment of minimum.

Geopolitical lockout. If FEOC rules and European content requirements exclude Chinese-controlled suppliers regardless of where the plant sits, roughly USD 480 million of committed overseas capital becomes stranded and Tinci remains a domestic Chinese business competing in the world's most crowded materials market.

Capital markets overhang. Tinci's board approved an H-share issuance on 4 July 2025, filed with the Hong Kong Stock Exchange on 22 September 2025, and refiled updated materials on 27 March 2026 with JPMorgan, CITIC Securities and GF Securities as joint sponsors.²²²³ The offering was reported as likely to exceed USD 1 billion. As of the March 2026 progress announcement it remained subject to approval from the China Securities Regulatory Commission, the Hong Kong Securities and Futures Commission and the exchange, and no completed listing had been publicly disclosed as of early September 2026.²³ Investors should hold two things simultaneously: an H-share listing would give Tinci hard currency for Morocco and Texas and a genuine international capital platform, and it would also dilute existing holders at a moment when earnings are running at or near a cyclical high. The executives who sold in February and March were selling into that same window.¹¹

Capital returns, for context. For the 2025 financial year the board proposed a cash dividend of RMB 3 per 10 shares plus a special "return to shareholders" distribution, with no bonus issue or capitalisation of reserves.³ Against 2025 earnings per share of RMB 0.71, the ordinary component alone represented a payout ratio above 40% — a reasonable posture for a company with heavy committed capital expenditure, and a more shareholder-friendly one than the industry norm. It is a modest but genuine data point on the side of capital discipline, and it sits awkwardly alongside a simultaneous plan to raise more than USD 1 billion in Hong Kong. Paying out cash while preparing to issue equity is not irrational when the uses are different — dividends from domestic cash flow, offshore equity for offshore plants — but investors are entitled to ask which signal to believe.

Weighing it

The claim that survives all of this is narrower than the bull case as usually told, and still substantial: Tinci is the structural low-cost producer in a commodity it does not control the price of, serving buyers more powerful than itself, in a market with a second demand engine emerging. That combination produces violent earnings cyclicality around a rising volume trend, not a compounding margin. The 2022 incentive targets, the 2024 collapse and the 2026 surge are all the same phenomenon viewed at different points on the curve.

What would confirm the stronger version of the thesis: overseas revenue reaching double digits as a share of total with above-group margins, and a full cycle in which the trough return on equity holds in the low teens rather than the low single digits. What would falsify it: another downcycle in which Tinci's returns again fall to the level of 2024 despite deeper integration, or a receivables event that turns paper profit into a write-off.

The three KPIs that matter

Everything above reduces to three things worth tracking, and only three.

1. Electrolyte shipment volume and global share. Volume is the cleanest read on whether the cost position is actually winning business, and it is the one metric that rose straight through the worst pricing environment the industry has known — from 396,000 tonnes in 2023 to over 720,000 in 2025 and more than 440,000 in a single half in 2026.¹⁴⁷² If share stalls or reverses while the industry grows, the moat thesis is in trouble regardless of what margins do in a given quarter.

2. Self-supply ratio for LiPF6 and LiFSI. This is the mechanism the entire cost advantage runs through, and it is currently the company's weakest disclosure. Investors should watch not just the level but whether Tinci begins reporting it consistently in its periodic filings. Improvement in the ratio during a period of rising salt prices is what converts a price spike into profit; deterioration would mean Tinci is buying salt at the market like everyone else.

3. Operating cash flow relative to net profit, read alongside receivables. Not gross margin — margin is a price signal and will oscillate with the cycle no matter what management does. Cash conversion is the signal that tells you whether the reported profit is real, whether the customer base is healthy, and whether the growth is being financed by the company's own balance sheet. On this measure the first half of 2026 was the weakest strong half-year Tinci has ever reported, and it is the number that would show trouble first.

↑ Back to Top

X. Epilogue & Key Takeaways

There is a photograph that does not exist but should: Xu Jinfu in 1995, back in Guangzhou on borrowed money after a failed venture in his home town, about to start a company that would make shampoo ingredients. Thirty-one years later, that company supplies more than a third of the world's lithium battery electrolyte, and its founder still owns roughly a third of it.³

The broader lessons from Tinci's trajectory differ from the conventional narrative.

Formulation was the entry ticket; process engineering was the business. Tinci's origin in personal-care chemistry gave it impurity control, formulation discipline, and customer-audit readiness — necessary conditions for battery materials, and the reason it could enter the market at all. But formulation skill is widely held; a dozen Chinese companies can blend a competent electrolyte. What separated Tinci was refusing to accept that LiPF6 had to be crystallised, and then rebuilding its entire cost structure around liquid-phase synthesis. For specialty chemicals investors, the general principle is clear: ask whether a company's advantage lives in a recipe, which competitors can approximate, or in a process, which requires rebuilding a plant to copy. In Tinci's case, a rival concluded it was cheaper to bribe an engineer than to invent the process independently, and a court agreed that was a crime.[^22]

M&A for qualification is powerful, and the accounting will not show it. The Kaixin acquisition bought a position in ATL's supply chain that could not be secured on the same timeline any other way, even as the acquired business promptly failed its earn-out targets and lost money.⁵¹³ Both facts are true. Investors evaluating customer-access acquisitions should expect this pattern: a target's standalone economics may be poor, but the strategic value resides in the customer qualification option — a value that rarely shows up on a goodwill impairment test in an easily readable form.

Surviving troughs is a strategy, but it is not a free one. Tinci's vertical integration allowed it to maintain positive earnings through 2024 while unintegrated blenders lost money, emerging from the downturn with higher market share. That is the consolidation mechanism working as intended. What integration did not do was protect returns on capital, prevent a 92% earnings decline, or stop the anchor customer from diversifying at the first opportunity.⁴⁷ A low-cost position provides insurance against extinction, not against cyclical pain — and it is paid for with capital deployed at market peaks, some of which is inevitably wasted, as a levelled field and a paved road outside Nantong attest.⁸

Concentration is a decision, not an accident, and it carries a bill. For nearly a decade, Tinci chose customer depth over breadth while its closest competitor pursued diversification. Both strategies remained defensible until the anchor customer's contract lapsed. The bill arrived in a single quarter of narrative volatility and a scramble to re-contract nearly three million tonnes of forward volume.¹²⁷ Tinci ultimately secured replacement commitments. However, the broader takeaway for supplier businesses is clear: the year a concentrated customer relationship looks most valuable — when the long-term contract is signed and the stock rallies — is precisely when the option to diversify is cheapest and least likely to be exercised.

Cyclicals reward investors who can hold opposing signals simultaneously. Tinci's reported profit in the first half of 2026 reached an all-time high, even as its cash conversion was among the weakest.² Its market position has never been stronger, yet its largest customer has never been less committed. The company is constructing factories on two continents while 97% of its revenue originates from a single domestic market.² These are not contradictions to reconcile; they reflect the inherent structure of a commodity supplier navigating a volatile cycle. The company that emerges from the next downcycle will clarify which set of facts mattered most.

For now, the verifiable facts remain specific. Tinci produces the lowest-cost tonne of lithium battery electrolyte globally, in an industry where cost leadership is essential but guarantees no permanent pricing power. It has proven it can survive an extreme market glut. It has not yet proven it can generate adequate returns on capital consistently across a full cycle. The moment profits surge and aggressive growth targets return is precisely when that historical record warrants the closest scrutiny.

Guangzhou Tinci Materials Technology Co., Ltd.

Table of Contents

Guangzhou Tinci Materials Technology: The Invisible Chemist Powering the EV Revolution

I. Introduction & Episode Roadmap

II. Fine Chemistry Roots: The Shampoo Era (2000–2007)

III. The Strategic Pivot & The Liquid LiPF6 Revolution (2007–2014)

IV. The Catalyst M&A: Dongguan Kaixin & The CATL Alliance (2015–2020)

V. The Great Boom, Glut, and Vertical Integration Moat (2021–2026)

VI. Current Management, Ownership, & Governance Stress Test

VII. Global Footprint & Geopolitical Risk Radar

VIII. Strategic Frameworks: Helmer's 7 Powers & Porter's 5 Forces

IX. Investment Spine & Bear vs. Bull Case

Myth versus reality

The bull case, and the evidence behind it

The bear case, and where it bites

Weighing it

The three KPIs that matter

X. Epilogue & Key Takeaways

References